BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates

  March 9, 2026

   · 

  8 min read
• Press Releases

  Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering

  March 9, 2026

   · 

  5 min read
• Press Releases

  Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4) - March 9, 2026

  March 9, 2026

   · 

  4 min read
• Press Releases

  Xenon Pharmaceuticals Announces Proposed Public Offering - March 9, 2026

  March 9, 2026

   · 

  4 min read
• Press Releases

  Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 9, 2026

  March 9, 2026

   · 

  2 min read
• Press Releases

  C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 9, 2026

  March 9, 2026

   · 

  1 min read
• Press Releases

  Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference 2026

  March 9, 2026

   · 

  1 min read
• Press Releases

  Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting

  March 9, 2026

   · 

  12 min read
• Press Releases

  Mineralys Therapeutics Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults with Hypertension and Topline Explore-OSA Trial Results

  March 9, 2026

   · 

  10 min read
• Press Releases

  SAB BIO Reports Full Year 2025 Financial Results and Business Highlights

  March 9, 2026

   · 

  8 min read